← All trials
NCT01359878
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2011
- Primary completion
- May 1, 2013
- Completion date
- Jul 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 249
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of CopenhagenLead sponsor
- University of CopenhagenOverall official - principal investigator
- University of CopenhagenStudy chair
- University of CopenhagenCollaborator
- Hans og Nora Buchards FondCollaborator
- Blood Bank of the Danish capital regionCollaborator
- Danish Council for Independent ResearchCollaborator
- Laerdal Acute FoundationCollaborator
- Aase and Ejnar Danielsens FoundationCollaborator
- The Foundation of 17.12.1981Collaborator
- Haemonetics CorporationCollaborator
- University of CopenhagenReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.